ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality

August 9, 1985

NCI Shifts Money to Save 100 Training Slots

July 14, 1989

House Bill Gives NCI $135 Million Increase, NIH $846 Million for FY 1988 Over 1987 Budgets

August 7, 1987

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

Grand Jury Clears Eppley, Shubik

October 24, 1980